A sub-group analysis of the MND patients (divided into PLS, ALS, ALS + FTD, and PMA, Figure 1B) did not show any difference in the CHI3L1 levels (p > 0.05). This evidence concerns the gene CHI3L1 and frontotemporal dementia.